[Antinuclear antibodies in autoimmune diseases]. 1982

P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune

Related Publications

P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn
August 1993, Rinsho byori. The Japanese journal of clinical pathology,
P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn
January 2017, Reumatologia,
P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn
May 1976, The Journal of pathology,
P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn
July 2018, Laboratory medicine,
P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn
April 2020, Nederlands tijdschrift voor geneeskunde,
P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn
January 2020, Clinical and experimental rheumatology,
P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn
January 1969, Lancet (London, England),
P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn
March 2020, Infectious diseases (London, England),
P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn
January 1973, Le Poumon et le coeur,
P Youinou, and Y Pennec, and P Le Goff, and P Miossec, and D Mottier, and A Missoum, and J M Boles, and G Le Menn
October 1971, Przeglad lekarski,
Copied contents to your clipboard!